Abstract
To the Editor. —Despite physician awareness of the benefits of preconception glycemic control of diabetes mellitus, many diabetic women of childbearing age are either unaware or unmotivated to optimize control of their diabetes before becoming pregnant. The benefits of preconception glycemic control, including a reduction in the risk of fetal anomalies to that of a normal nondiabetic population 1,2 and a significant decrease in the rate of spontaneous abortion 3,4 have been well established. Implementing a plan to encourage universal prepregnancy diabetes control should be a major priority. We propose a straightforward and inexpensive tactic to improve compliance with preconception diabetes control programs: put a warning label regarding pregnancy and birth defects on the equipment that diabetic patients routinely use for their daily care. The devices and supplies to be labeled could include insulin syringes, glucose meters, blood glucose monitoring strips, lancets, finger-pricking devices, and urine glucose test strips. The
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
